Conversely, in the setting of autoimmune diseases such as SLE, it remains less clear whether anti-IFN antibodies contribute to disease pathogenesis, or serve as markers of aberrant IFN signaling. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.